CTS 10-Q Quarterly Report Oct. 3, 2010 | Alphaminr
ALPHAMINR

CTS 10-Q Quarter ended Oct. 3, 2010

Balance Sheet
Cash Flow
Income Statement
Debt
CTS CORP
10-Ks and 10-Qs
10-Q
Quarter ended Sept. 30, 2025
10-Q
Quarter ended June 30, 2025
10-Q
Quarter ended March 31, 2025
10-K
Fiscal year ended Dec. 31, 2024
10-Q
Quarter ended Sept. 30, 2024
10-Q
Quarter ended June 30, 2024
10-Q
Quarter ended March 31, 2024
10-K
Fiscal year ended Dec. 31, 2023
10-Q
Quarter ended Sept. 30, 2023
10-Q
Quarter ended June 30, 2023
10-Q
Quarter ended March 31, 2023
10-K
Fiscal year ended Dec. 31, 2022
10-Q
Quarter ended Sept. 30, 2022
10-Q
Quarter ended June 30, 2022
10-Q
Quarter ended March 31, 2022
10-K
Fiscal year ended Dec. 31, 2021
10-Q
Quarter ended Sept. 30, 2021
10-Q
Quarter ended June 30, 2021
10-Q
Quarter ended March 31, 2021
10-K
Fiscal year ended Dec. 31, 2020
10-Q
Quarter ended Sept. 30, 2020
10-Q
Quarter ended June 30, 2020
10-Q
Quarter ended March 31, 2020
10-K
Fiscal year ended Dec. 31, 2019
10-Q
Quarter ended Sept. 30, 2019
10-Q
Quarter ended June 30, 2019
10-Q
Quarter ended March 31, 2019
10-K
Fiscal year ended Dec. 31, 2018
10-Q
Quarter ended Sept. 30, 2018
10-Q
Quarter ended June 30, 2018
10-Q
Quarter ended March 31, 2018
10-K
Fiscal year ended Dec. 31, 2017
10-Q
Quarter ended Sept. 30, 2017
10-Q
Quarter ended June 30, 2017
10-Q
Quarter ended March 31, 2017
10-K
Fiscal year ended Dec. 31, 2016
10-Q
Quarter ended Sept. 30, 2016
10-Q
Quarter ended June 30, 2016
10-Q
Quarter ended March 31, 2016
10-K
Fiscal year ended Dec. 31, 2015
10-Q
Quarter ended Sept. 27, 2015
10-Q
Quarter ended June 28, 2015
10-Q
Quarter ended March 29, 2015
10-K
Fiscal year ended Dec. 31, 2014
10-Q
Quarter ended Sept. 28, 2014
10-Q
Quarter ended June 29, 2014
10-Q
Quarter ended March 30, 2014
10-K
Fiscal year ended Dec. 31, 2013
10-Q
Quarter ended Sept. 29, 2013
10-Q
Quarter ended June 30, 2013
10-Q
Quarter ended March 31, 2013
10-K
Fiscal year ended Dec. 31, 2012
10-Q
Quarter ended Sept. 30, 2012
10-Q
Quarter ended July 1, 2012
10-Q
Quarter ended April 1, 2012
10-K
Fiscal year ended Dec. 31, 2011
10-Q
Quarter ended Oct. 2, 2011
10-Q
Quarter ended July 3, 2011
10-Q
Quarter ended April 3, 2011
10-K
Fiscal year ended Dec. 31, 2010
10-Q
Quarter ended Oct. 3, 2010
10-Q
Quarter ended July 4, 2010
10-Q
Quarter ended April 4, 2010
10-K
Fiscal year ended Dec. 31, 2009
PROXIES
DEF 14A
Filed on May 8, 2025
DEF 14A
Filed on March 28, 2025
DEF 14A
Filed on May 9, 2024
DEF 14A
Filed on March 29, 2024
DEF 14A
Filed on March 31, 2023
DEF 14A
Filed on May 12, 2022
DEF 14A
Filed on April 1, 2022
DEF 14A
Filed on April 1, 2021
DEF 14A
Filed on April 2, 2020
DEF 14A
Filed on April 4, 2019
DEF 14A
Filed on April 5, 2018
DEF 14A
Filed on April 5, 2017
DEF 14A
Filed on April 7, 2016
DEF 14A
Filed on April 9, 2015
DEF 14A
Filed on April 11, 2014
DEF 14A
Filed on April 17, 2013
DEF 14A
Filed on April 17, 2012
DEF 14A
Filed on April 19, 2011
DEF 14A
Filed on April 20, 2010
10-Q 1 form10q.htm FORM 10-Q3-10 form10q.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q

(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended October 3, 2010
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from _______________ to _______________

Commission File Number: 1-4639

CTS CORPORATION
(Exact name of registrant as specified in its charter)

Indiana
35-0225010
(State or other jurisdiction of incorporation or organization)
(IRS Employer Identification Number)

905 West Boulevard North, Elkhart, IN
46514
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code: 574-523-3800

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or shorter period that the registrant was required to submit and post such files).
Yes o No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See definition of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o Accelerated filer x Non-accelerated filer (Do not check if smaller reporting company) o

Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of October 25, 2010: 34,183,382.


CTS CORPORATION AND SUBSIDIARIES


Page
FINANCIAL INFORMATION
Item 1.
3
3
- For the Three and Nine Months Ended October 3, 2010 and September 27, 2009
4
- As of October 3, 2010 and December 31, 2009
5
- For the Nine Months Ended October 3, 2010 and September 27, 2009
6
- For the Three and Nine Months Ended October 3, 2010 and  September 27, 2009
7
Item 2.
16
Item 3.
25
Item 4.
25
OTHER INFORMATION
Item 1.
25
Item 1A.
26
Item 6.
26
27




PART I - FINANCIAL INFORMATION

CTS CORPORATION AND SUBSIDIARIES
(In thousands, except per share amounts)

Three Months Ended
Nine Months Ended
October 3,
2010
September 27, 2009
October 3,
2010
September 27, 2009
Net sales
$ 139,362 $ 126,565 $ 407,616 $ 365,094
Costs and expenses:
Cost of goods sold
109,393 100,380 316,828 297,202
Selling, general and administrative expenses
17,112 16,494 54,944 48,357
Research and development expenses
5,086 3,408 13,985 10,227
Restructuring charge – Note I
— — — 2,243
Goodwill impairment
— — — 33,153
Operating earnings/(loss)
7,771 6,283 21,859 (26,088 )
Other (expense)/income:
Interest expense
(254 ) (256 ) (717 ) (1,615 )
Interest income
105 17 239 118
Other
1,738 (390 ) 917 (736 )
Total other income/(expense)
1,589 (629 ) 439 (2,233 )
Earnings/(loss) before income taxes
9,360 5,654 22,298 (28,321 )
Income tax expense
2,445 1,173 5,060 9,872
Net earnings/(loss)
$ 6,915 $ 4,481 $ 17,238 $ (38,193 )
Net earnings/(loss) per share - Note J
Basic
$ 0.20 $ 0.13 $ 0.51 $ (1.13 )
Diluted
$ 0.20 $ 0.13 $ 0.50 $ (1.13 )
Cash dividends declared per share
$ 0.03 $ 0.03 $ 0.09 $ 0.09
Average common shares outstanding:
Basic
34,181 33,873 34,060 33,799
Diluted
34,827 34,513 34,816 33,799


See notes to unaudited condensed consolidated financial statements.


CTS CORPORATION AND SUBSIDIARIES
(In thousands of dollars)


October 3,
2010
December 31, 2009
ASSETS
Current Assets
Cash and cash equivalents
$
73,031
$
51,167
Accounts receivable, less allowances (2010 - $1,705;  2009- $2,119)
90,136
71,718
Inventories, net - Note D
76,562
54,348
Other current assets
19,325
16,502
Total current assets
259,054
193,735
Property, plant and equipment, less accumulated depreciation (2010 - $247,564; 2009 - $264,651)
79,409
81,120
Other Assets
Prepaid pension asset
32,621
29,373
Goodwill – Note L
500
500
Other intangible assets, net – Note L
32,056
33,938
Deferred income taxes
66,662
68,331
Other
579
660
Total other assets
132,418
132,802
Total Assets
$
470,881
$
407,657

LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities
Accounts payable
$
70,534
$
52,344
Accrued liabilities
41,201
38,172
Total current liabilities
111,735
90,516
Long-term debt  - Note E
77,100
50,400
Other long-term obligations
16,902
19,287
Shareholders’ Equity
Preferred stock - authorized 25,000,000 shares without par value; none issued
—
—
Common stock - authorized 75,000,000 shares without par value; 54,504,141 shares issued
at October 3, 2010 and 54,213,931 shares issued at December 31, 2009
285,350
282,491
Additional contributed capital
36,886
37,675
Retained earnings
331,750
317,582
Accumulated other comprehensive loss
(91,833
)
(93,285
)
562,153
544,463
Cost of common stock held in treasury (2010 and 2009 – 20,320,759 shares)
(297,009
)
(297,009
)
Total shareholders’ equity
265,144
247,454
Total Liabilities and Shareholders’ Equity
$
470,881
$
407,657
See notes to unaudited condensed consolidated financial statements.






CTS CORPORATION AND SUBSIDIARIES
(In thousands of dollars)


Nine Months Ended
October 3,
2010
September 27,
2009
Cash flows from operating activities:
Net earnings/(loss)
$
17,238
(38,193
)
Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:
Depreciation and amortization
13,244
14,919
Prepaid pension asset
(5,985
)
(5,853
)
Equity-based compensation – Note B
2,911
2,711
Restructuring and impairment charges – Note I
—
2,243
Goodwill impairment – Note L
—
33,153
Amortization of retirement benefit adjustments – Note F
3,646
3,942
Other
(987
)
7,389
Changes in assets and liabilities, net of acquisitions
Accounts receivable
(17,929
)
20,045
Inventories
(21,587
)
11,031
Other current assets
(2,697
)
1,600
Accounts payable and accrued liabilities
20,241
(18,936
)
Total adjustments
(9,143
)
72,244
Net cash provided by operating activities
8,095
34,051
Cash flows from investing activities:
Earnout payment related to a 2008 acquisition
(500
)
—
Capital expenditures
(10,505
)
(4,681
)
Proceeds from sales of assets
1,530
1,309
Net cash used in investing activities
(9,475
)
(3,372
)
Cash flows from financing activities:
Payment of 2.125% Debentures
—
(32,500
)
Payments of long-term debt – Note E
(2,488,950
)
(2,141,050
)
Proceeds from borrowings of long-term debt – Note E
2,515,650
2,142,550
Payments of short-term notes payable
(2,258
)
(7,755
)
Proceeds from borrowings of short-term notes payable
2,258
7,755
Dividends paid
(3,063
)
(3,040
)
Other
69
(929
)
Net cash provided by/(used in) financing activities
23,706
(34,969
)
Effect of exchange rate on cash and cash equivalents
(462
)
(9
)
Net increase/(decrease) in cash and cash equivalents
21,864
(4,299
)
Cash and cash equivalents at beginning of year
51,167
44,628
Cash and cash equivalents at end of period
$
73,031
$
40,329
Supplemental cash flow information
Cash paid during the period for:
Interest
$
633
$
728
Income taxes—net
$
2,370
$
5,915

See notes to unaudited condensed consolidated financial statements.



CTS CORPORATION AND SUBSIDIARIES
(In thousands of dollars)


Three Months Ended
Nine Months Ended
October 3,
2010
September 27, 2009
October 3,
2010
September 27, 2009
Net earnings/(loss)
$
6,915
$
4,481
$
17,238
$
(38,193
)
Other comprehensive earnings/(loss):
Cumulative translation adjustment
1,090
(352
)
(546
)
1,925
Amortization of retirement benefit adjustments (net of tax)
582
779
1,998
2,253
Comprehensive earnings/(loss)
$
8,587
$
4,908
$
18,690
$
(34,015
)

See notes to unaudited condensed consolidated financial statements.


NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - UNAUDITED
October 3, 2010

NOTE A – Basis of Presentation
The accompanying condensed consolidated financial statements have been prepared by CTS Corporation (“CTS” or “the Company”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to such rules and regulations. The unaudited condensed consolidated financial statements should be read in conjunction with the financial statements, notes thereto, and other information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2009.
The accompanying unaudited condensed consolidated financial statements reflect, in the opinion of management, all adjustments (consisting of normal recurring items) necessary for a fair statement, in all material respects, of the financial position and results of operations for the periods presented.  The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period.  Actual results could differ materially from those estimates.  The results of operations for the interim periods are not necessarily indicative of the results for the entire year.
NOTE B – Equity-Based Compensation

At October 3, 2010, CTS had five equity-based compensation plans:  the 1996 Stock Option Plan (“1996 Plan”), the 2001 Stock Option Plan (“2001 Plan”), the Nonemployee Directors’ Stock Retirement Plan (“Directors’ Plan”), the 2004 Omnibus Long-Term Incentive Plan (“2004 Plan”), and the 2009 Omnibus Equity and Performance Incentive Plan (“2009 Plan”).  All of these plans, except the Directors’ Plan, were approved by shareholders. As of December 31, 2009, additional grants can only be made under the 2004 and 2009 Plans. CTS believes that equity based awards align the interest of employees with those of its shareholders.

The 2009 Plan, and previously the 1996 Plan, 2001 Plan and 2004 Plan, provides for grants of incentive stock options or nonqualified stock options to officers, key employees, and nonemployee members of CTS’ board of directors.  In addition, the 2009 Plan and the 2004 Plan allows for grants of stock appreciation rights, restricted stock, restricted stock units, performance shares, performance units, and other stock awards.

The following table summarizes the compensation expense included in the Unaudited Condensed Consolidated Statements of Earnings/(Loss) for the three and nine months ended October 3, 2010 and September 27, 2009 relating to these plans:
Three Months Ended
Nine Months Ended
($ in thousands)
October 3
2010
September 27, 2009
October 3.
2010
September 27,
2009
Stock options
$ — $ 2 $ 3 $ 34
Restricted stock units
746 907 2,908 2,677
Total
$ 746 $ 909 $ 2,911 $ 2,711

The following table summarizes the status of these plans as of October 3, 2010:

2009 Plan
2004 Plan
2001 Plan
1996 Plan
Awards originally available
3,400,000
6,500,000
2,000,000
1,200,000
Stock options outstanding
—
276,850
709,013
128,350
Restricted stock units outstanding
515,494
265,004
—
—
Options exercisable
—
276,850
709,013
128,350
Awards available for grant
2,751,449
268,500
—
—




Stock Options
Stock options are exercisable in cumulative annual installments over a maximum 10-year period, commencing at least one year from the date of grant.   Stock options are generally granted with an exercise price equal to the market price of the Company’s stock on the date of grant.  The stock options generally vest over four years and have a 10-year contractual life.  The awards generally contain provisions to either accelerate vesting or allow vesting to continue on schedule upon retirement if certain service and age requirements are met.   The awards also provide for accelerated vesting if there is a change in control event.

The Company estimates the fair value of the stock option on the grant date using the Black-Scholes option-pricing model and assumptions for expected price volatility, option term, risk-free interest rate, and dividend yield.  Expected price volatilities are based on historical volatilities of the Company’s stock.  The expected option term is derived from historical data on exercise behavior.  The dividend yield is based on historical dividend payments.  The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.

A summary of the status of stock options as of October 3, 2010 and September 27, 2009, and changes during the nine-month periods then ended, is presented below:

October 3, 2010
September 27, 2009
Options
Weighted-Average
Exercise Price
Options
Weighted-Average
Exercise Price
Outstanding at beginning of year
1,179,088 $ 13.72 1,294,263 $ 14.53
Exercised
(17,000 ) $ 7.70 — $ —
Expired
(47,875 ) $ 42.30 (109,675 ) $ 21.45
Forfeited
— $ — — $ —
Outstanding at end of period
1,114,213 $ 12.59 1,184,588 $ 13.89
Exercisable at end of period
1,114,213 $ 12.59 1,163,838 $ 13.89


The total intrinsic value of share options exercised during the nine-month period ended October 3, 2010 was $30,000.  There were no share options exercised during the nine-month period ended September 27, 2009.

The weighted-average remaining contractual life of options outstanding and options exercisable at October 3, 2010 is 2.4 years. The aggregate intrinsic value of options outstanding and options exercisable at October 3, 2010 is approximately $550,000.

A summary of the nonvested stock options as of October 3, 2010 and September 27, 2009, and changes during the nine-month periods then ended, is presented below:

October 3, 2010
September 27, 2009
Options
Weighted-average
Grant-Date
Fair Value
Options
Weighted-average
Grant-Date
Fair Value
Nonvested at beginning of year
20,750 $ 6.24 74,525 $ 6.36
Vested
(20,750 ) $ 6.24 (53,775 ) $ 6.41
Forfeited
— $ — — $ —
Nonvested at end of period
— $ — 20,750 $ 6.24

The total fair value of options vested during the nine-month periods ended October 3, 2010 and September 27, 2009 was approximately $130,000 and $345,000, respectively. As of October 3, 2010, there was no unrecognized compensation cost related to nonvested stock options.  CTS recognized expense on a straight-line basis over the requisite service period for each separately vesting portion of the award as if the award was, in substance, multiple awards.


The following table summarizes information about stock options outstanding at October 3, 2010:

Options Outstanding
Options Exercisable
Weighted Average
Range of
Number
Remaining
Weighted Average
Number
Weighted Average
Exercise
Outstanding
Contractual
Exercise
Exercisable
Exercise
Prices
at 10/3/10
Life (Years)
Price
At 10/3/10
Price
$
7.70 – 11.11
708,663
2.89
$
9.41
708,663
$
9.41
$
13.68 – 16.24
227,800
2.98
$
14.12
227,800
$
14.12
$
23.00 – 25.10
177,250
0.55
$
23.24
177,250
$
23.24
$
42.69
500
0.11
$
42.69
500
$
42.69

Service-Based Restricted Stock Units

Service-based restricted stock units (“RSUs”) entitle the holder to receive one share of common stock for each unit when the unit vests.  RSUs are issued to officers and key employees as compensation.  Generally, the RSUs vest over a three-year period.  A summary of the status of RSUs as of October 3, 2010 and September 27, 2009, and changes during the nine-month periods then ended is presented below:

October 3, 2010
September 27, 2009
RSUs
Weighted-average
Grant-Date
Fair Value
RSUs
Weighted-average
Grant-Date
Fair Value
Outstanding at beginning of year
854,745 $ 8.47 700,358 $ 10.76
Granted
282,200 $ 7.59 390,850 $ 6.09
Converted
(282,895 ) $ 9.01 (217,991 ) $ 10.70
Forfeited
(73,552 ) $ 7.49 (22,180 ) $ 1132
Outstanding at end of period
780,498 $ 8.39 851,037 $ 8.61
Weighted-average remaining contractual life
5.3 years
4.7 years

CTS recorded compensation expense of approximately $471,000 and $2,015,000 related to service-based restricted stock units during the three and nine month periods ended October 3, 2010, respectively.  CTS recorded compensation expense of approximately $663,000 and $1,971,000 related to service-based restricted stock units during the three and nine month periods ended September 27, 2009, respectively.

As of October 3, 2010, there was $2.1 million of unrecognized compensation cost related to nonvested RSUs.  That cost is expected to be recognized over a weighted-average period of 1.2 years.  CTS recognizes expense on a straight-line basis over the requisite service period for each separately vesting portion of the award as if the award was, in substance, multiple awards.

Performance-Based Restricted Stock Units
On February 6, 2007, CTS granted performance-based restricted stock unit awards for certain executives.  Executives received a total of 17,100 units based on achievement of year-over-year sales growth and free cash flow performance goals for fiscal year 2007.  These units will cliff vest and convert one-for-one to CTS common stock on December 31, 2010.

On February 5, 2008, CTS granted performance-based restricted stock unit awards to certain executives. Vesting may occur, if at all, at a rate from zero percent to 200% of the target amount of 42,200 units in 2010 subject to certification of the 2009 fiscal year results by CTS’ independent auditors. Vesting is dependent upon CTS’ achievement of sales growth targets. No awards were granted as the sales growth targets were not met.

On February 2, 2010, CTS granted performance-based restricted stock unit awards for certain executives. Vesting may occur in the range from zero percent to 200% of the target amount of 78,000 units in 2012 subject to certification of the 2011 fiscal year results by CTS’ independent auditors. Vesting is dependent upon CTS’ achievement of sales growth targets.

CTS recorded compensation expense of approximately $87,000 and $264,000 related to performance-based restricted stock units during the three and nine month periods ended October 3, 2010, respectively.  CTS recorded compensation expense of approximately $34,000 and $85,000 related to performance-based restricted stock units during the three and nine month periods ended September 27, 2009, respectively.  As of October 3, 2010 there was approximately $420,000 of unrecognized compensation cost related to performance-based RSUs.  That cost is expected to be recognized over a weighted-average period 1.0 year.

Market-Based Restricted Stock Units

On July 2, 2007, CTS granted a market-based restricted stock unit award for an executive officer.  An aggregate of 25,000 units may be earned in performance years ending in the following three consecutive years on the anniversary of the award date.  Vesting may occur in the range from zero percent to 150% of the target award on the end date of each performance period and is tied exclusively to CTS total stockholder return relative to 32 enumerated peer group companies’ total stockholder return rates.  The vesting rate will be determined using a matrix based on a percentile ranking of CTS total stockholder return with peer group total shareholder return over a three-year period.

On February 5, 2008, CTS granted market-based restricted stock unit awards for certain executives.  In the first half of 2010, 57,300 restricted stock units were vested. Such vesting was dependent upon CTS’ total stockholder return relative to 29 enumerated peer group companies’ stockholder return rates.

On February 4, 2009, CTS granted market-based restricted stock unit awards for certain executives and key employees.  Vesting may occur in the range from zero percent to 200% of the target amount of 128,000 units in 2011.  Vesting is dependent upon CTS total stockholder return relative to 28 enumerated peer group companies’ stockholder return rates.

On February 2, 2010, CTS granted market-based restricted stock unit awards for certain executives and key employees.  Vesting may occur in the range from zero percent to 200% of the target amount of 117,000 units in 2012.  Vesting is dependent upon CTS total stockholder return relative to 28 enumerated peer group companies’ stockholder return rates.

CTS recorded compensation expense of approximately $188,000 and $629,000 related to market-based restricted stock units during the three and nine month periods ended October 3, 2010, respectively.  CTS recorded compensation expense of approximately $210,000 and $621,000 related to market-based restricted stock units during the three and nine month periods ended September 27, 2009, respectively. As of October 3, 2010, there was approximately $800,000 of unrecognized compensation cost related to market-based RSUs.  That cost is expected to be recognized over a weighted-average period of 1.0 year.

Stock Retirement Plan
The Directors’ Plan provides for a portion of the total compensation payable to nonemployee directors to be deferred and paid in CTS stock.  The Directors’ Plan was frozen effective December 1, 2004.  All future grants will be from the 2004 Plan.
NOTE C—Fair Value Measurement

The table below summarizes the financial liability that was measured at fair value on a recurring basis as of October 3, 2010:

($ in thousands)
Carrying Value at October 3, 2010
Quoted Prices in Active Markets for Identical (Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Long-term debt
$
77,100
$
—
$
77,100
$
—

The table below summarizes the financial liability that was measured at fair value on a recurring basis as of December 31, 2009:

($ in thousands)
Carrying Value at December 31, 2009
Quoted Prices in Active Markets for Identical (Level 1)
Significant Other Observable Inputs
(Level 2)
Significant Unobservable Inputs
(Level 3)
Long-term debt
$
50,400
$
—
$
50,400
$
—

CTS’ long-term debt consists of a revolving debt agreement.  There is a readily determinable market for CTS’ revolving credit debt and is classified within Level 2 of the fair value hierarchy as the market is not deemed to be active.  The fair value of long-term debt was measured using a market approach which uses current industry information.


NOTE D – Inventories, net
Inventories consist of the following:
($ in thousands)
October 3,
2010
December 31,
2009
Finished goods
$
6,357
$
7,220
Work-in-process
17,331
12,941
Raw materials
52,874
34,187
Total inventories, net
$
76,562
$
54,348
NOTE E – Debt

Long-term debt was comprised of the following:

($ in thousands)
October 3,
2010
December 31,
2009
Revolving credit agreement, weighted-average interest rate of 1.0% (2010), and 1.1%
(2009) due in 2011
$ 77,100 $ 50,400

On June 27, 2006, CTS entered into a $100 million, unsecured revolving credit agreement.  Under the terms of the revolving credit agreement, CTS can expand the credit facility to $150 million, subject to participating banks’ approval.  There was $77.1 million and $50.4 million outstanding under the revolving credit agreement at October 3, 2010 and December 31, 2009, respectively.  At October 3, 2010 and December 31, 2009, CTS had $20.1 million and $46.8 million available under this agreement, net of standby letters of credit of $2.8 million, respectively. Interest rates on the revolving credit agreement fluctuate based upon LIBOR and the Company’s quarterly total leverage ratio. CTS pays a commitment fee on the undrawn portion of the revolving credit agreement.  The commitment fee varies based on the quarterly leverage ratio and was .15 percent per annum at October 3, 2010.  The revolving credit agreement requires, among other things, that CTS comply with a maximum total leverage ratio and a minimum fixed charge coverage ratio.  Failure of CTS to comply with these covenants could reduce the borrowing availability under the revolving credit agreement.  CTS was in compliance with all debt covenants at October 3, 2010.  The revolving credit agreement requires CTS to deliver quarterly financial statements, annual financial statements, auditors certifications and compliance certificates within a specified number of days after the end of a quarter and year-end. Additionally, the revolving agreement contains restrictions limiting CTS' ability to: dispose of assets; incur certain additional debt; repay other debt or amend subordinated debt instruments; create liens on assets; make investments, loans or advances; make acquisitions or engage in mergers or consolidations; engage in certain transactions with CTS' subsidiaries and affiliates; and the amounts allowed for stock repurchases and dividend payments. The revolving credit agreement expires in June 2011. CTS has the intent and ability to renew its obligation incurred under the revolving credit agreement for a period extending beyond one year from the balance-sheet date on or before the expiration date.

NOTE F – Retirement Plans
Net pension (income)/postretirement expense for the three and nine-months ended October 3, 2010 and September 27, 2009 include the following components:
Three Months Ended
Nine Months Ended
($ in thousands)
October 3,
2010
September 27, 2009
October 3,
2010
September 27, 2009
PENSION PLANS
Service cost
$ 746 $ 788 $ 2,236 $ 2,346
Interest cost
3,315 3,396 9,957 10,268
Expected return on plan assets (1)
(6,086 ) (6,108 ) (18,247 ) (18,305 )
Settlement cost
— — 234 —
Amortization of prior service cost
153 126 663 378
Amortization of loss
993 1,198 2,983 3,640
Net pension income
$ (879 ) $ (600 ) $ (2,174 ) $ (1,673 )
______________________________________
1) Expected return on plan assets is net of expected investment expenses and certain administrative expenses.






Three Months Ended
Nine Months Ended
($ in thousands)
October 3,
2010
September 27, 2009
October 3,
2010
September 27, 2009
OTHER POSTRETIREMENT BENEFIT PLAN
Service cost
$ 3 $ 3 $ 10 $ 8
Interest cost
75 78 225 235
Amortization of gain
— (25 ) — (76 )
Net postretirement expense
$ 78 $ 56 $ 235 $ 167
NOTE G – Segments
CTS’ reportable segments are grouped by entities that exhibit similar economic characteristics and the segments’ reporting results are regularly reviewed by CTS’ chief operating decision maker to make decisions about resources to be allocated to these segments and to evaluate the segments’ performance.
CTS has two reportable segments: 1) EMS and 2) Components and Sensors. EMS includes the higher level assembly of electronic and mechanical components into a finished subassembly or assembly performed under a contract manufacturing agreement with an original equipment manufacturer (“OEM”) or other contract manufacturer.  Additionally, for some customers, CTS provides full turnkey manufacturing and completion including design, bill-of-material management, logistics, and repair.
Components and sensors are products which perform specific electronic functions for a given product family and are intended for use in customer assemblies.  Components and sensors consist principally of automotive sensors and actuators used in commercial or consumer vehicles; electronic components used in communications infrastructure and computer markets; terminators used in computer and other high speed applications, switches, resistor networks, and potentiometers used to serve multiple markets.
The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in the Company’s annual report on Form 10-K.  Management evaluates performance based upon segment operating earnings before restructuring and restructuring-related charges, goodwill impairment, interest expense, other non-operating income, and income tax expense.

Summarized financial information concerning CTS’ reportable segments is shown in the following table:

($ in thousands)
EMS
Components and Sensors
Total
Third Quarter of 2010
Net sales to external customers
$
67,592
$
71,770
$
139,362
Segment operating earnings
$
72
$
7,699
$
7,771
Total assets
$
137,615
$
333,266
$
470,881
Third Quarter of 2009
Net sales to external customers
$
70,737
$
55,828
$
126,565
Segment operating earnings
$
2,214
$
4,069
$
6,283
Total assets
$
122,937
$
283,743
$
406,680
First Nine Months of 2010
Net sales to external customers
$
190,175
$
217,441
$
407,616
Segment operating (loss)/earnings
$
(2,807
)
$
24,666
$
21,859
Total assets
$
137,615
$
333,266
$
470,881
First Nine Months of 2009
Net sales to external customers
$
217,366
$
147,728
$
365,094
Segment operating earnings
$
6,559
$
2,749
$
9,308
Total assets
$
122,937
$
283,743
$
406,680




Reconciling information between reportable segments’ operating earnings and CTS’ consolidated pre-tax income is shown in the following table:
Three Months Ended
Nine Months Ended
($ in thousands)
October 3,
2010
September 27, 2009
October 3,
2010
September 27, 2009
Total segment operating earnings
$ 7,771 $ 6,283 $ 21,859 $ 9,308
Restructuring and related charges
— — — (2,243 )
Goodwill impairment
— — — (33,153 )
Interest expense
(254 ) (256 ) (717 ) (1,615 )
Interest income
105 17 239 118
Other income/(expense)
1,738 (390 ) 917 (736 )
Earnings/(loss) before income taxes
$ 9,360 $ 5,654 $ 22,298 $ (28,321 )
NOTE H – Contingencies
Certain processes in the manufacture of CTS’ current and past products create hazardous waste by-products as currently defined by federal and state laws and regulations. CTS has been notified by the U.S. Environmental Protection Agency, state environmental agencies and, in some cases, generator groups, that it is or may be a potentially responsible party regarding hazardous waste remediation at several non-CTS sites. In addition to these non-CTS sites, CTS has an ongoing practice of providing reserves for probable remediation activities at certain of its manufacturing locations and for claims and proceedings against CTS with respect to other environmental matters. In the opinion of management, based upon presently available information relating to all such matters, either adequate provision for probable costs has been made, or the ultimate costs resulting will not materially affect the consolidated financial position, results of operations, or cash flows of CTS.

CTS manufactures accelerator pedals for a number of automobile manufacturers, including subsidiaries of Toyota Motor Corporation (“Toyota”). In January 2010, Toyota initiated a recall of approximately 2.3 million vehicles in North America containing pedals manufactured by CTS. The pedal recall and associated events have led to the Company being named as a co-defendant with Toyota in certain litigation. In February 2010, CTS entered into an agreement with Toyota whereby Toyota agreed that it will indemnify, defend, and hold the Company harmless from, and the parties will cooperate in the defense of, third-party civil claims and actions that are filed or asserted in the United States or Canada and that arise from or relate to alleged incidents of unintended acceleration of Toyota and Lexus vehicles. The limited exceptions to indemnification restrict CTS’ share of any liability to amounts collectable from its insurers.

Certain other claims are pending against CTS with respect to matters arising out of the ordinary conduct of the Company’s business. For all other claims, in the opinion of management, based upon presently available information, either adequate provision for anticipated costs has been accrued or the ultimate anticipated costs will not materially affect CTS’ consolidated financial position, results of operations, or cash flows.
NOTE I – Restructuring

In March 2009, CTS initiated certain restructuring actions to reorganize certain operations to further improve its cost structure.  These actions resulted in the elimination of approximately 268 positions and were completed in the first quarter of 2009.

The following table displays the planned restructuring and restructuring-related charges associated with the realignment, as well as a summary of the actual costs incurred through March 29, 2009:

($ in millions) March 2009 Plan
Planned
Costs
Actual incurred through
March 29, 2009
Workforce reduction
$ 1.9 $ 2.1
Asset impairments
— 0.1
Total restructuring and impairment charge
$ 1.9 $ 2.2

Of the restructuring and impairment costs incurred, $2.1 million relates to the Components and Sensors segment and $0.1 million relates to the EMS segment.  Restructuring charges are reported on a separate line on the Unaudited Consolidated Statements of Earnings/ (Loss) and the restructuring-related costs are included in cost of goods sold.



The following table displays the restructuring reserve activity related to the realignment for the period ended March 29, 2009:

($ in millions) March 2009 Plan
Restructuring liability at January 1, 2009
$
—
Restructuring and restructuring-related charges, excluding asset impairments and write-offs
2.1
Cost paid
(2.1
)
Restructuring liability at December 31, 2009
$
—

NOTE J –Earnings/(Loss) Per Share
The table below provides a reconciliation of the numerator and denominator of the basic and diluted earnings/ (loss) per share (“EPS”) computations. Basic earnings/ (loss) per share is calculated using the weighted average number of common shares outstanding as the denominator and net earnings/ (loss) as the numerator. Diluted earnings/ (loss) per share is calculated by adding all potentially dilutive shares to the weighted average number of common shares outstanding for the numerator. All anti-dilutive shares are excluded from the computation of diluted earnings/ (loss) per share. The calculations below provide net earnings, average common shares outstanding, and the resultant earnings per share for both basic and diluted EPS for the three and nine-month periods ended October 3, 2010 and September 27, 2009.
($ in thousands, except per share amounts)
Net Earnings/(Loss)
(Numerator)
Shares
(in thousands) (Denominator)
Per Share Amount
Third Quarter 2010
Basic EPS
$
6,915
34,181
$
0.20
Effect of dilutive securities:
Equity-based compensation plans
—
646
Diluted EPS
$
6,915
34,827
$
0.20
Third Quarter 2009
Basic EPS
$
4,481
33,873
$
0.13
Effect of dilutive securities:
Equity-based compensation plans
—
640
Diluted EPS
$
4,481
34,513
$
0.13
First Nine Months of 2010
Basic EPS
$
17,238
34,060
$
0.51
Effect of dilutive securities:
Equity-based compensation plans
—
756
Diluted EPS
$
17,238
34,816
$
0.50
First Nine Months of 2009
Basic EPS
$
(38,193
)
33,799
$
(1.13
)
Effect of dilutive securities:
Equity-based compensation plans
—
—
Diluted EPS
$
(38,193
)
33,799
$
(1.13
)
The following table shows the potentially dilutive securities which have been excluded from the three and nine-month periods 2010 and 2009 dilutive earnings per share calculation because they are either anti-dilutive, or the exercise price exceeds the average market price.

Three Months Ended
Nine Months Ended
(Number of Shares in Thousands)
October 3,
2010
September 27, 2009
October 3,
2010
September 27, 2009
Stock options where the assumed proceeds exceeds the
average market price
866
919
866
1,134
Restricted stock units
—
—
—
582
Securities related to the subordinated convertible debt
—
—
—
984




NOTE K – Treasury Stock

Common stock held in treasury totaled 20,320,759 shares with a cost of $297.0 million, at October 3, 2010 and December 31, 2009. Approximately 6.5 million shares are available for future issuances.

In May 2008, CTS’ Board of Directors authorized a program to repurchase up to one million shares of its common stock in the open market at a maximum price of $13 per share.  The authorization has no expiration. Reacquired shares will be used to support equity-based compensation programs and for other corporate purposes.  No shares were repurchased under this program in 2009 and 2010 year-to-date.

NOTE L – Goodwill and Other Intangible Assets

CTS has the following other intangible assets and goodwill as of:

October 3, 2010
December 31, 2009
($ in thousands)
Gross Carrying Amount
Accumulated Amortization
Gross Carrying Amount
Accumulated Amortization
Amortized intangible assets:
Customer lists/relationships
$
51,084
$
(19,388
)
$
51,084
$
(17,544
)
Patents
10,319
(10,319
)
10,319
(10,319
)
Other intangibles
500
(140
)
500
(102
)
Total
61,903
(29,847
)
61,903
(27,965
)
Goodwill
500
—
500
—
Total other intangible assets and goodwill
$
62,403
$
(29,847
)
$
62,403
$
(27,965
)

Of the net intangible assets at October 3, 2010, $7.5 million relates to the EMS segment and $25.1 million relates to the Components and Sensors segment. CTS recorded amortization expense of $0.6 million and $1.9 million during the three and nine-month periods ended October 3, 2010, respectively.  CTS recorded amortization expense of $0.6 million and $2.4 million during the three and nine-month periods ended September 27, 2009, respectively.  CTS estimates remaining amortization expense of $0.6 million in 2010, $2.4 million per year in years 2011 through 2014, and $21.9 million thereafter.

In light of a continuous decline in CTS’ market capitalization in the first quarter of 2009, CTS determined that an interim impairment test was necessary at the end of the first quarter of 2009 for two of its reporting units.  After completing step one of the prescribed test, CTS determined that the estimated fair values of both reporting units were less than their book values on March 29, 2009. CTS performed the step two test and concluded that the reporting units’ goodwill were impaired. As a result, an impairment loss of $33.2 million was recorded in the first quarter of 2009. Of the $33.2 million impairment loss, $30.8 million was related to the EMS segment and $2.4 million was related to the Components and Sensors segment.  This non-cash goodwill impairment had no impact on CTS’ debt covenants.


NOTE M – Recent Accounting Pronouncements

ASU 2010-06, “Fair Value Measurements and Disclosures – Improving Disclosures about Fair Value Measurements”

In January 2010, the FASB issued ASU 2010-06, “Fair Value Measurements and Disclosures – Improving Disclosures about Fair Value Measurements” (“ASU 2010-06”), that amends ASC Subtopic 820-10, “Fair Value Measurements and Disclosures – Overall”, and requires reporting entities to disclose (1) the amount of significant transfers in and out of Level 1 and Level 2 fair value measurements and describe the reasons for the transfers, and (2) separate information about purchases, sales, issuance and settlements in the reconciliation of fair value measurements using significant unobservable inputs (Level 3).  ASU 2010-06 also requires reporting entities to provide fair value measurement disclosures for each class of assets and liabilities and disclose the inputs and valuation techniques for fair value measurements that fall within Levels 2 and 3 of the fair value hierarchy.  These disclosures and clarification are effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuance, and settlements in the rollforward of activity in Level 3 fair value measurements.  Those disclosures are effective for fiscal years beginning after December 15, 2010 and for interim periods within those fiscal years.  The Company adopted the provisions of ASU 2010-06 and the provisions of ASU 2010-06 did not have a material impact on CTS’ consolidated financial statements.

ASU 2010-09, “Subsequent Events – Amendments to Certain Recognition and Disclosure Requirements”

In February 2010, the FASB issued ASU 2010-09, “Subsequent Events – Amendments to Certain Recognition and Disclosure Requirements” (“ASU 2010-09”), that amends ASC Subtopic 855-10, “Subsequent Events – Overall” (“ASC 855-10”). ASU 2010-09 requires an SEC filer to evaluate subsequent events through the date that the financial statements are issued but removed the requirement to disclose this date in the notes to the entity’s financial statements. The amendments are effective upon issuance of the final update and accordingly, CTS has adopted the provisions of ASU 2010-09. The adoption of these provisions did not have a material impact on CTS’ consolidated financial statements.




Overview

CTS Corporation (“we”, “our”, “us”) is a global manufacturer of components and sensors used primarily in the automotive, communications and defense and aerospace markets.  We also provide electronic manufacturing solutions, including design and supply chain management functions, primarily serving the defense and aerospace, communications, industrial and medical markets under contract arrangements with original equipment manufacturers.

As discussed in more detail throughout the MD&A:

·
Total sales in the third quarter of 2010 of $139.4 million were reported through two segments, Components and Sensors and EMS.  Sales increased by $12.8 million, or 10.1%, in the third quarter of 2010 from the third quarter of 2009.  Sales in the Components and Sensors segment increased by 28.6% versus the third quarter of 2009, while sales in the EMS segment decreased by 4.4%.

·
Gross margin as a percent of sales was 21.5% in the third quarter of 2010 compared to 20.7% in the third quarter of 2009 due to favorable segment sales mix and improved absorption of fixed costs on higher sales.  The Components and Sensors segment, which inherently generates a higher gross margin, increased to 51.5% of total company sales in the third quarter of 2010 compared to 44.1% of total sales in the same period of 2009.

·
Selling, general and administrative (“SG&A”) expenses were $17.1 million, or 12.3% of sales, in the third quarter of 2010 versus $16.5 million, or 13.0% of sales in the third quarter of 2009.

·
Research and development (“R&D”) expenses were $5.1 million, or 3.6% of sales, in the third quarter of 2010 compared to $3.4 million, or 2.7% of sales, in the third quarter of 2009.  This increase of $1.7 million reflects higher spending on new product development and new growth initiatives.

·
Income tax expense and effective tax rate for the third quarter of 2010 were $2.4 million and 26.1% respectively versus $1.2 million and 20.7% in the same quarter 2009.

·
Net earnings were $6.9 million, or $0.20 per diluted share, in the third quarter of 2010.  This compares with $4.5 million, or $0.13 per diluted share, in the third quarter of 2009.


Critical Accounting Policies
MD&A discusses our unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America.  The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Management believes that judgment and estimates related to the following critical accounting policies could materially affect our consolidated financial statements:

·
Inventory valuation, the allowance for doubtful accounts, and other accrued liabilities
·
Long-lived and intangible assets valuation, and depreciation/amortization periods
·
Income taxes
·
Retirement plans
·
Equity-based compensation
In the third quarter of 2010, there were no changes in the above critical accounting policies.


Results of Operations

Comparison of Third Quarter 2010 and Third Quarter 2009
Segment Discussion
Refer to Note G, “Segments”, for a description of our segments.
The following table highlights the segment results for the quarters ending October 3, 2010 and September 27, 2009:

($ in thousands)
Components & Sensors
EMS
Consolidated
Total
Third Quarter 2010
Sales
$
71,770
$
67,592
$
139,362
Segment operating earnings
7,699
$
72
$
7,771
% of sales
10.7
%
0.1
%
5.6
%
Third Quarter 2009
Sales
$
55,828
$
70,737
$
126,565
Segment operating earnings
4,069
$
2,214
$
6,283
% of sales
7.3
%
3.1
%
5.0
%

Sales in the Components and Sensors segment increased $15.9 million, or 28.6%, from the third quarter of 2009 primarily attributable to an increase in automotive market sales of $7.2 million, reflecting improvement in global light vehicle production and new product introductions, and higher electronic component sales of $8.7 million due to generally improved economic trends driving increased customer demand and new product introductions.

The Components and Sensors segment recorded operating earnings of $7.7 million in the third quarter of 2010 versus $4.1 million in the third quarter of 2009.  The favorable earnings change resulted primarily from higher sales, offset by higher R&D costs of $1.7 million to develop and launch new growth initiatives.

Sales in the EMS segment decreased $3.1 million, or 4.4%, in the third quarter of 2010 from the third quarter of 2009.  The decrease in sales was primarily attributable to lower sales of $5.6 million in the defense and aerospace and $3.5 million in medical markets due to reduced customer demand and timing of new programs, partially offset by increases in the industrial and communications markets of $4.5 million and $2.0 million, respectively.

EMS segment operating earnings was $0.1 million in the third quarter of 2010 versus earnings of $2.2 million in the third quarter 2009.  The unfavorable earnings change was primarily due to lower sales and unfavorable product mix.


Total Company Discussion

The following table highlights changes in significant components of the Unaudited Condensed Consolidated Statements of Earnings for the quarters ended October 3, 2010 and September 27, 2009:

Quarter ended
($ in thousands, except net earnings per share)
October 3,
2010
September 27, 2009
Increase
(Decrease)
Net sales
$
139,362
$
126,565
$
12,797
Gross margin
$
29,969
$
26,185
$
3,784
% of net sales
21.5
%
20.7
%
0.8
%
Selling, general and administrative expenses
$
17,112
$
16,494
$
618
% of net sales
12.3
%
13.0
%
(0.7
)%
Research and development expenses
$
5,086
$
3,408
$
1,678
% of net sales
3.6
%
2.7
%
0.9
%
Operating earnings
$
7,771
$
6,283
$
1,488
% of net sales
5.6
%
5.0
%
0.6
%
Interest and other income/(expense)
$
1,589
$
(629
)
$
2,218
% of net sales
1.1
%
(0.5
)%
1.6
%
Income tax expense
$
2,445
$
1,173
$
1,272
Net earnings
$
6,915
$
4,481
$
2,434
% of net sales
5.0
%
3.5
%
1.5
%
Net earnings per diluted share
$
0.20
$
0.13
$
0.07

Sales of $139.4 million in the third quarter of 2010 increased $12.8 million, or 10.1%, from the third quarter of 2009 primarily attributable to an increase in automotive market sales of $7.2 million, reflecting improvement in global light vehicle production and new product introductions, and higher electronic component sales of $8.7 million due to increased customer demand and new product introductions.  EMS segment sales decrease of $3.1 million was primarily attributable to lower sales of $5.6 million in the defense and aerospace and $3.5 million in medical markets due to reduced customer demand and timing of new programs, partially offset by increases in the industrial and communications markets of $4.5 million and $2.0 million, respectively, due to higher customer demand resulting from generally improved economic trends.

Gross margin as a percent of sales was 21.5% in the third quarter of 2010 compared to 20.7% in the third quarter of 2009 due to favorable segment sales mix and improved absorption of fixed costs on higher sales.  The Components and Sensors segment, which inherently generates a higher gross margin, increased to 51.5% of total company sales in the third quarter of 2010 compared to 44.1% of total sales in the same period of 2009.

SG&A expenses were $17.1 million, or 12.3% of sales, in the third quarter of 2010 versus $16.5 million, or 13.0% of sales, in the third quarter of 2009.  SG&A expenses as a percentage of sales improved slightly due to the fact that sales grew at a higher rate than that of SG&A in spite of the reinstatement of certain compensation-related items that were temporarily suspended during 2009 due to the recessionary economic environment.

R&D expenses were $5.1 million, or 3.6% of sales, in the third quarter of 2010 compared to $3.4 million, or 2.7% of sales, in the third quarter of 2009.  The increase as a percentage of sales was primarily driven by spending to develop and launch new growth initiatives.  R&D expenses are incurred by the Components and Sensors segment and are primarily focused on expanded applications of existing products and new product development, as well as current product and process enhancements.

Operating earnings were $7.8 million in the third quarter of 2010 compared to $6.3 million in the third quarter of 2009.

Interest and other income was $1.6 million in the third quarter of 2010 versus $0.6 million expense in the same quarter 2009 due to the favorable impact of the weakening of the U.S. dollar relative to most of the currencies of the countries where we do business.

The effective tax rate for third quarter 2010 was 26.1% compared to 20.7% in the third quarter of 2009.  The increase in effective tax rate was primarily due to changes in the mix of earnings by jurisdiction as more income was earned in locations with higher marginal tax rates and an increase in the valuation allowance at one of our foreign units.
Net earnings were $6.9 million, or $0.20 per diluted share, in the third quarter of 2010 compared with a net income of $4.5 million, or $0.13 per share, in the third quarter of 2009.

Comparison of First Nine Months 2010 and First Nine Months 2009
Segment Discussion

The following table highlights the segment results for the nine-month periods ending October 3, 2010 and September 27, 2009:

($ in thousands)
Components & Sensors
EMS
Consolidated
Total
First Nine Months 2010
Sales
$
217,441
$
190,175
$
407,616
Segment operating earnings/(loss)
$
24,666
$
(2,807
)
$
21,859
% of sales
11.3
%
(1.5
)%
5.4
%
First Nine Months 2009
Sales
$
147,728
$
217,366
$
365,094
Segment operating earnings
$
2,749
$
6,559
$
9,308
% of sales
1.9
%
3.0
%
2.5
%

Sales in the Components and Sensors segment increased $69.7 million, or 47.2%, from the first nine months of 2009, primarily attributable to an increase in automotive market sales of $44.6 million, reflecting improvement in global light vehicle production and higher electronic component sales of $25.1 million due to generally improved economic trends driving increased customer demand and new product introductions.

The Components and Sensors segment recorded operating earnings of $24.7 million in the first nine months of 2010 versus $2.7 million in the first nine months of 2009.  The favorable earnings change resulted primarily from the higher sales, partially offset by higher R&D costs of $3.8 million to develop and launch new growth initiatives.
Sales in the EMS segment decreased $27.2 million, or 12.5%, in the first nine months of 2010 versus the first nine months of 2009.  The decrease in sales was primarily attributable to lower sales of $24.5 million in the defense and aerospace market, $15.2 million in the computer market and $10.0 million the medical market due to reduced customer demand, offset by higher sales in the communications and industrial markets of $12.7 million in the communications, $5.5 million in the industrial markets and $4.3 million in the other markets.  The decrease in sales in the computer market was driven by $15.4 million lower sales to our customer Hewlett-Packard due to a product that essentially reached end-of-life in 2009. End-of-life typically means that the product is no longer required by the customer due to a design change or technological advancement.

EMS segment operating losses were $2.8 million in the first nine months of 2010 versus earnings of $6.6 million in the first nine months of 2009.  The unfavorable earnings change was primarily due to lower sales and unfavorable product mix.




Total Company Discussion

The following table highlights changes in significant components of the Unaudited Condensed Consolidated Statements of Earnings for the nine-month periods ended October 3, 2010 and September 27, 2009:

Nine months ended
($ in thousands, except net earnings per share)
October 3,
2010
September 27, 2009
Increase
(Decrease)
Net sales
$
407,616
$
365,094
$
42,522
Gross margin
$
90,788
$
67,892
$
22,896
% of net sales
22.3
%
18.6
%
3.7
%
Selling, general and administrative expenses
$
54,944
$
48,357
$
6,587
% of net sales
13.5
%
13.2
%
0.3
%
Research and development expenses
$
13,985
$
10,227
$
3,758
% of net sales
3.4
%
2.8
%
0.6
%
Restructuring charge
$
—
$
2,243
$
(2,243
)
% of net sales
—
%
0.6
%
(0.6
)%
Goodwill impairment
$
—
$
33,153
$
(33,153
)
% of net sales
—
%
9.1
%
(9.1
)%
Operating earnings/(loss)
$
21,859
$
(26,088
)
$
47,947
% of net sales
5.4
%
(7.1
)%
12.5
%
Interest and other income/(expense)
$
439
$
(2,233
)
$
2,672
% of net sales
0.1
%
(0.6
)%
0.7
%
Income tax expense
$
5,060
$
9,872
$
(4,812
)
Net earnings/(loss)
$
17,238
$
(38,193
)
$
55,431
% of net sales
4.2
%
(10.5
)%
14.7
%
Net earnings/(loss) per diluted share
$
0.50
$
(1.13
)
$
1.63

Sales of $407.6 million in the first nine months of 2010 increased $42.5 million, or 11.6%, from the first nine months of 2009, primarily attributed to increased automotive product sales of $44.6 million, reflecting improvement in global light vehicle production, and higher electronic component sales of $25.1 million due to increased customer demand and new product introductions.  EMS segment sales decrease of $27.2 million was primarily attributable to lower sales of $24.5 million in the defense and aerospace market, $15.2 million in the computer market and $10.0 million the medical market due to reduced customer demand, offset by higher sales of $12.7 million in the communications, $5.5 million in the industrial markets and $4.3 million in the other markets.  The decrease in sales in the computer market was driven by $15.4 million lower sales to our customer Hewlett-Packard due to a product that essentially reached end-of-life in 2009. End-of-life typically means that the product is no longer required by the customer due to a design change or technological advancement.

Gross margin as a percent of sales was 22.3% in the first nine months of 2010 compared to 18.6% in the first nine months of 2009 due to favorable segment sales mix and improved absorption of fixed costs on higher sales.  The Components and Sensors segment, which inherently generates a higher gross margin increased to 53.3% of total company sales in the first nine months of 2010 compared to 40.5% of total sales in the same period of 2009.

SG&A expenses were $54.9 million, or 13.5% of sales, in the first nine months of 2010 versus $48.4 million, or 13.2% of sales, in the first nine months of 2009.  SG&A expenses as a percentage of sales slightly increased primarily attributable to an increased spending of approximately $5.1 million to support higher sales and $1.6 million resulting from the reinstatement of certain compensation-related items  that were temporarily suspended during 2009 due to the recessionary economic environment.

R&D expenses were $14.0 million, or 3.4% of sales, in the first nine months of 2010 versus $10.2 million, or 2.8% of sales, in the first nine months of 2009.  The slight increase as a percentage of sales was primarily driven by spending to develop and launch new growth initiatives.  R&D expenses are incurred by the Components and Sensors segment and are primarily focused on expanded applications of existing products and new product development, as well as current product and process enhancements.

Operating earnings were $21.9 million in the first nine months of 2010 compared to a loss of $26.1 million in the first nine months of 2009.  The first nine months of 2009 included a $33.2 million goodwill impairment charge and approximately $2.2 million of restructuring costs associated with the restructuring actions announced in March 2009.  No such costs were incurred in the first nine months of 2010.

Interest and other income in the first nine months of 2010 was $0.4 million versus interest and other expenses of $2.2 million in the same period of 2009.  The income in 2010 primarily resulted from a foreign currency exchange gain of $1.7 million due to the favorable weakening of the U.S. dollar relative to most of the currencies of the countries where we do business, and $0.9 million lower net interest expense due to lower outstanding debt in 2010.

The effective tax rate for the first nine months of 2010 was 22.7%.  Comparatively, the effective tax rate for the first nine months of 2009 was (34.9)%.  On a year-to-date basis, income tax expense in the amount of $5.1 million was recorded during the first nine months of 2010 compared to $9.9 million during the first nine months of 2009.  The 2009 expense included a tax expense of $9.1 million related to cash repatriation and a tax benefit of $0.2 million related to goodwill impairment.  Excluding these items, the adjusted tax rate for the first nine months of 2009 was 20.7%.  Compared to the 2009 adjusted tax rate, tax expense increased due to changes in the mix of earnings by jurisdiction as more income was earned in locations with higher marginal tax rates.

Net earnings of $17.2 million, or $0.50 per diluted share, in the first nine months of 2010 compared with a net loss of $38.2 million, or $1.13 per share, in the first nine months of 2009 which included $0.98 per share for non-cash goodwill impairment, a tax expense of $0.27 per share related to cash repatriation and $0.05 per share of restructuring charges.


Reconciliation of Effective Tax Rate as Reported to Adjusted Tax Rate

For the Nine-month Period Ended September 27, 2009
Pre-tax loss
$
(28,321
)
Income tax expense
$
9,872
Effective tax rate
(34.9
)%
Pre-tax loss
$
(28,321
)
Add:
Goodwill impairment charges
33,153
Adjusted Pre-tax earnings
$
4,832
Income tax expense
$
9,872
Subtract:
Tax expense related to cash repatriation and goodwill impairment charges
(8,872
)
Adjusted tax benefit
$
1,000
Adjusted tax rate
20.7
%

Adjusted tax rate is a non-GAAP financial measure.  The most directly comparable GAAP financial measure is effective tax rate.  We calculate adjusted tax rate to exclude the impact of our goodwill impairment charge from our pre-tax loss and the tax impacts related to this charge and cash repatriation. We exclude the impacts of these items as they have significant impacts on comparable GAAP financial measures and could distort an evaluation of our normal operating performance.



Toyota Recall

We manufacture accelerator pedals for a number of automobile manufacturers, including subsidiaries of Toyota Motor Corporation (“Toyota”).  In January 2010, Toyota initiated a recall of approximately 2.3 million vehicles in North America containing pedals manufactured by us.  We responded to an inquiry from the National Highway Traffic Safety Administration, which has since closed, and subpoenas from a United States Attorney and the Securities and Exchange Commission related to this event.  The pedal recall and associated events also led to our being named as a co-defendant with Toyota in certain litigation.  In February 2010, we entered into an agreement with Toyota whereby Toyota agreed that it will indemnify, defend, and hold us harmless from, and the parties will cooperate in the defense of, third-party civil claims and actions that are filed or asserted in the United States or Canada and that arise from or relate to alleged incidents of unintended acceleration of Toyota and Lexus vehicles.  The limited exceptions to indemnification restrict our share of any liability to amounts collectible from our insurers.

To date, costs related to the Toyota recall have been immaterial.


Outlook

Based on our year-to-date results and current outlook, and assuming no new economic weakness, management anticipates full-year 2010 diluted earnings per share in the range of $0.60 to $0.65, which is higher than our previous guidance of $0.55 to $0.62.  Full-year 2010 sales are estimated to increase by 10%-15% over 2009.

Liquidity and Capital Resources

Overview

Cash and cash equivalents were $73.0 million at October 3, 2010 and $51.2 million at December 31, 2009.  Total debt on October 3, 2010 was $77.1 million, compared to $50.4 million at the end of 2009, as we increased debt primarily to fund domestic working capital requirements as sales increased.  Total debt as a percentage of total capitalization was 22.5% at the end of the third quarter of 2010, compared with 16.9% at the end of 2009.  Total debt as a percentage of total capitalization is defined as the sum of notes payable, current portion of long-term debt and long-term debt as a percentage of total debt and shareholders’ equity.

Working capital increased $44.1 million in the third quarter of 2010 versus year-end 2009, primarily due to increases in cash and cash equivalents of $21.9 million, inventory of $22.2 million and accounts receivable of $18.4 million, partially offset by an increase in accounts payable of $18.2 million.


Cash Flow

Operating Activities

Net cash provided by operating activities was $8.1 million during the first nine months of 2010.  Components of net cash provided by operating activities included net earnings of $17.2 million and depreciation and amortization expense of $13.2 million, partially offset by net changes in assets and liabilities of $22.0 million and an increase in prepaid pension asset of $6.0 million.  The changes in assets and liabilities were primarily due to increased inventories of $21.6 million and increased accounts receivable of $17.9 million partially offset by increased accounts payable and accrued liabilities of $20.2 million, all to support higher sales.

Net cash provided by operating activities was $34.1 million during the first nine months of 2009.  Components of net cash provided by operating activities include a net loss of $38.2 million, restructuring and asset impairment charges of $35.4 million, depreciation and amortization expense of $14.9 million and net changes in assets and liabilities of $13.7 million, partially offset by an increase in prepaid pension asset of $5.9 million.  The changes in assets and liabilities were primarily due to decreased accounts receivable of $20.0 million and decreased inventories of $11.0 million, partially offset by decreased accounts payable and accrued liabilities of $18.9 million.



Investing Activities

Net cash used in investing activities for the first nine months of 2010 was $9.5 million, primarily for capital expenditures of $10.5 million, partially offset by proceeds of $1.5 million received from the sales of an idle facility and undeveloped land.

Net cash used in investing activities was $3.4 million for the first nine months of 2009, for capital expenditures of $4.7 million, partially offset by proceeds of $1.1 million received from the sale of an idle facility.

Financing Activities

Net cash provided by financing activities for the first nine months of 2010 was $23.7 million, consisting primarily of a net increase in long-term debt of $26.7 million, offset by $3.1 million in dividend payments.  The additional debt was primarily used to meet usual working capital requirements as sales increased.

Net cash used by financing activities for the first nine months of 2009 was $35.0 million, primarily from paying off the remaining aggregate principal amount of senior subordinated debentures in May 2009.

Capital Resources

Refer to Note E, “Debt,” for further discussion.

On June 27, 2006, we entered into a $100 million, unsecured revolving credit agreement.  Under the terms of the revolving credit agreement, we can expand the credit facility to $150 million, subject to participating banks’ approval.  There was $77.1 million and $50.4 million outstanding under the revolving credit agreement at October 3, 2010 and December 31, 2009, respectively.  At October 3, 2010 and December 31, 2009, we had $20.1 million and $46.8 million available under this agreement, net of standby letters of credit of $2.8 million, respectively. Interest rates on the revolving credit agreement fluctuate based upon LIBOR and our quarterly total leverage ratio. We pay a commitment fee on the undrawn portion of the revolving credit agreement.  The commitment fee varies based on the quarterly leverage ratio and was 0.15 percent per annum at October 3, 2010.  The revolving credit agreement requires, among other things, that we comply with a maximum total leverage ratio and a minimum fixed charge coverage ratio.  Failure to comply with these covenants could reduce the borrowing availability under the revolving credit agreement.  We were in compliance with all debt covenants at October 3, 2010.  The revolving credit agreement requires us to deliver quarterly financial statements, annual financial statements, auditors certifications and compliance certificates within a specified number of days after the end of a quarter and year-end.  Additionally, the revolving agreement contains restrictions limiting our ability to: dispose of assets; incur certain additional debt; repay other debt or amend subordinated debt instruments; create liens on assets; make investments, loans or advances; make acquisitions or engage in mergers or consolidations; engage in certain transactions with our subsidiaries and affiliates; and the amounts allowed for stock repurchases and dividend payments. The revolving credit agreement expires in June 2011. We have the intent and ability to renew its obligation incurred under the revolving credit agreement for a period extending beyond one year from the balance-sheet date on or before the expiration date.

In May 2008, our Board of Directors authorized a program to repurchase up to one million shares of our common stock in the open market at a maximum price of $13.00 per share.  The authorization has no expiration.  Reacquired shares will be used to support equity-based compensation programs and for other corporate purposes.  No shares were repurchased under this program in 2009 or for the nine-month period ended October 3, 2010.

We have historically funded our capital and operating needs primarily through cash flows from operating activities, supported by available credit under our bank credit agreements.  We believe that expected positive cash flows from operating activities and available borrowings under current and future credit agreements will be adequate to fund our working capital, capital expenditures and debt service requirements for at least the next twelve months.



Recent Accounting Pronouncements

ASU 2010-06, “Fair Value Measurements and Disclosures – Improving Disclosures about Fair Value Measurements”

In January 2010, the FASB issued ASU 2010-06, “Value Measurements and Disclosures – Improving Disclosures about Fair Value Measurements” (“ASU 2010-06”), that amends ASC Subtopic 820-10, “Fair Value Measurements and Disclosures – Overall”, and requires reporting entities to disclose (1) the amount of significant transfers in and out of Level 1 and Level 2 fair value measurements and describe the reasons for the transfers, and (2) separate information about purchases, sales, issuance and settlements in the reconciliation of fair value measurements using significant unobservable inputs (Level 3).  ASU 2010-06 also requires reporting entities to provide fair value measurement disclosures for each class of assets and liabilities and disclose the inputs and valuation techniques for fair value measurements that fall within Levels 2 and 3 of the fair value hierarchy.  These disclosures and clarification are effective for interim and annual reporting periods beginning after December 15, 2009, except for the disclosures about purchases, sales, issuance, and settlements in the rollforward of activity in Level 3 fair value measurements.  Those disclosures are effective for fiscal years beginning after December 15, 2010 and for interim periods within those fiscal years.  We adopted the provisions of ASU 2010-06 and the provisions of ASU 2010-06 do not have a material impact on our consolidated financial statements.

ASU 2010-09, “Subsequent Events – Amendments to Certain Recognition and Disclosure Requirements”

In February 2010, the FASB issued ASU 2010-09, “Subsequent Events – Amendments to Certain Recognition and Disclosure Requirements” (“ASU 2010-09”), that amends ASC Subtopic 855-10, “Subsequent Events – Overall” (“ASC 855-10”). ASU 2010-09 requires an SEC filer to evaluate subsequent events through the date that the financial statements are issued but removed the requirement to disclose this date in the notes to the entity’s financial statements. The amendments are effective upon issuance of the final update and accordingly, we have adopted the provisions of ASU 2010-09. The adoption of these provisions does not have a material impact on our consolidated financial statements.

*****

Forward-Looking Statements

This document contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements include, but are not limited to, any financial or other guidance, statements that reflect our current expectations concerning future results and events, and any other statements that are not based solely on historical fact.  Forward-looking statements are based on management’s expectations, certain assumptions and currently available information.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.  These forward-looking statements are made subject to certain risks, uncertainties and other factors, which could cause our actual results, performance or achievements to differ materially from those presented in the forward-looking statements.  For more detailed information on the risks and uncertainties associated with our business, see our reports filed with the SEC.  Examples of factors that may affect future operating results and financial condition include, but are not limited to: rapid technological change; general market conditions in the automotive, communications, and computer industries, as well as conditions in the industrial, defense and aerospace, and medical markets; reliance on key customers; the ability to protect our intellectual property; pricing pressures and demand for our products; and risks associated with our international operations, including trade and tariff barriers, exchange rates and political and geopolitical risks.  We undertake no obligation to publicly update our forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.






There have been no other material changes in our market risk since December 31, 2009.
Pursuant to Rule 13a-15(e) of the Securities and Exchange Act of 1934, management, under the direction of our Chief Executive Officer and Chief Financial Officer, evaluated our disclosure controls and procedures.  Based on such evaluation our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of October 3, 2010.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting for the quarter ended October 3, 2010 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.
PART II - OTHER INFORMATION

We manufacture accelerator pedals for a number of automobile manufacturers, including subsidiaries of Toyota Motor Corporation (“Toyota”).  In January 2010, Toyota initiated a recall of approximately 2.3 million vehicles in North America containing pedals manufactured by CTS.  The pedal recall and associated events have led to us being named as a co-defendant with Toyota in certain litigation.

In February 2010, we entered into an agreement with Toyota whereby Toyota agreed that it will indemnify, defend, and hold us harmless from, and the parties will cooperate in the defense of, certain third-party civil claims and actions that are filed or asserted in the United States or Canada and that arise from or relate to alleged incidents of unintended acceleration of Toyota and Lexus vehicles.  If it is determined that CTS acted negligently in selecting materials or processes where we had sole control over the selection process, in failing to meet Toyota’s specifications, or in making unapproved changes in component design or materials, and such negligence caused or contributed to a claim, we will be responsible for any judgment that may be rendered against us individually, or any portion of a judgment that may be allocated to us, but limited only to the extent of insurance collected from our insurers.  Toyota would remain responsible to defend CTS in these actions and would remain responsible for any balance of the remaining liability over amounts recovered by insurance. The agreement also does not cover costs or liabilities in connection with government investigations, government hearings, or government recalls.

Presently, we have been served process and named as co-defendant with Toyota in approximately thirty-four open lawsuits; we have been dismissed as a defendant from an additional eighteen lawsuits.  The claims brought generally fall into two categories, those that allege sudden unintended acceleration of Toyota vehicles led to injury or death, and those that allege economic harm to owners of Toyota vehicles related to vehicle defects.  Some suits combine elements of both.  Claims include demands for compensatory and special damages.  To date, the only actions filed where we are aware we have been named as a co-defendant are civil actions filed in the Unites States or Canada. All currently open lawsuits are subject to the indemnification agreement described above.  Some of these lawsuits arise out of incidents involving models for which we do not manufacture the pedal, such as all Lexus models, the Toyota Prius, and the Toyota Tacoma, or for which we manufacture only a portion of the pedals, such as the Toyota Camry.  Many lawsuits have been consolidated in federal multidistrict litigation in the United States District Court, Southern District of California, though some remain in various other courts.

Certain processes in the manufacture of our current and past products create hazardous waste by-products as currently defined by federal and state laws and regulations.  We have been notified by the U.S. Environmental Protection Agency, state environmental agencies, and in some cases, generator groups, that we are or may be a potentially responsible party regarding hazardous waste remediation at several non-CTS sites.  In addition to these non-CTS sites, we have an ongoing practice of providing reserves for probable remediation activities at certain of our manufacturing locations and for claims and proceedings against us with respect to other environmental matters.  In the opinion of management, based upon all present available information relating to all such matters, either adequate provisions for probable costs has been made, or the ultimate costs resulting will not materially affect our consolidated financial position, results of operations, or cash flows.

Certain other claims are pending against us with respect to matters arising out of the ordinary conduct of our business.  For all other claims, in the opinion of management, based upon presently available information, either adequate provision for anticipated costs have been accrued or the ultimate anticipated costs will not materially affect our consolidated financial position, results of operations, or cash flows.


There have been no significant changes to our risk factors since December 31, 2009.

Letter Agreement dated February 19, 2010 by and among CTS Corporation, Toyota Motor Sales, U.S.A. Inc., Toyota Canada Inc. and Toyota Motor Engineering & Manufacturing North America, Inc.
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.




Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

CTS Corporation
CTS Corporation
/s/ Richard G. Cutter III
/s/ Donna L. Belusar
Richard G. Cutter III
Vice President, Secretary and General Counsel
Donna L. Belusar
Senior Vice President and Chief Financial Officer
Dated: October 27, 2010
Dated: October 27, 2010


27
TABLE OF CONTENTS